Grifols SA (GRFS) - Bozor kapitallashuvi
Grifols, S.A. (GRFS) kompaniyasining 2.29 indikatori bilan ko'rsatilgan ushbu kunlik narxlar grafigi plazma-o'rnini bosuvchi terapiyalar va diagnostika tizimlari sotuvidan daromad oladigan kompaniyaning bozor mavqeini namoyish etadi. Biznes past sikllilik bilan xarakterlanadi, garchi logistik qiyinchiliklar va qarz darajalari uning barqarorligini pasaytirsa-da. Tor ixtisoslashuv bilan bog'liq xatarlar global ustunlik va biomateriallar yig'ish markazlarining keng tarmog'iga egalik qilish orqali muvozanatga keltirilgan.
Grifols Biemat (GRFS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- bozor narxi va tahlilchilarning maqsadli narxlari:
- bozor kapitallashuvi ko'rsatkichlari:
- emitentning balans qiymati statistikasi:
- qarz yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Grifols, S.A.|GRFS - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Grifols, S.A.|GRFS - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati Grifols Biemat|GRFS - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzi Grifols|Tezkor likvidlik koeffitsiyenti grifols.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
GRFS - Sof foyda|Kelajakdagi foyda Grifols, S.A.|GRFS - Kompaniya qiymatining sof foydaga nisbati|Forvard P/E multiplikatori Grifols Group|GRFS - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Grifols Biemat|GRFS - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Grifols|GRFS - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi grifols.com|GRFS - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Grifols, S.A.
Kompaniyaning fundamental tahlili:GRFS (Grifols)
Emitentning investitsiya auditini o'tkazish umumiy biznes qiymatini aniqlash uchun joriy aksiya narxi va muomaladagi qimmatqog'ozlarning umumiy soni ko'paytmasi sifatida hisoblanadigan bozor kapitalizatsiyasini tahlil qilishni talab etadi. Grifols, S.A. (GRFS) uchun ushbu ko'rsatkich plazma asosidagi dori vositalari va diagnostika uskunalarini ishlab chiqarishdagi kengayish imkoniyatlari prizmasi orqali kompaniyaning birjada bozor qiymatini aks ettiradi va aktivning tizimli risklarga chidamliligini baholash imkonini beradi.
Muhim raqobatchilar
Bozor qiymati argenx ARGX|Bozor qiymati BNTX|Abivax S.A. - Bozor kapitallashuvi|Bozor bahosi ADMA|Protagonist Therapeutics (PTGX) - Bozor qiymati|IMVT - Bozor kapitallashuvi|Bozor qiymati Kiniksa|Adaptive Biotech - Bozor bahosi|Bozor kapitallashuvi CLDX|AUPH (Aurinia Corp) - Bozor qiymati|Bozor kapitallashuvi BCRX (BioCryst)|Bozor kapitallashuvi veratx.com VERA|DNTH - Bozor qiymati|Bozor qiymati PHVS (Pharvaris NV)|AbCellera (ABCL) - Bozor qiymati|Bozor bahosi Tourmaline|PGEN (Precigen, Inc.) - Bozor kapitallashuvi|Bozor kapitallashuvi pharming.com|Bozor bahosi NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio, Inc.) - Bozor qiymati|Bozor kapitallashuvi ZBIO (Zenas Biopharma, Inc.)|Bozor kapitallashuvi Immunome Bio (IMNM)|GOSS - Bozor qiymati|kalvista.com (KALV) - Bozor bahosi|Septerna (SEPN) - Bozor qiymati|Bozor bahosi Pieris Pharma|Bozor bahosi SVRA|Bozor kapitallashuvi Rigel Corp|Bozor qiymati AnaptysBio, Inc. (ANAB)|astriatx.com - Bozor kapitallashuvi|Bozor kapitallashuvi ENGN (enGene)|rapt.com (RAPT) - Bozor qiymati|Aerovate - Bozor kapitallashuvi|Bozor kapitallashuvi Aclaris Therapeutics, Inc (ACRS)|Kyverna Therapeutics (KYTX) - Bozor qiymati|tizianalifesciences.com - Bozor qiymati|CABA (Cabaletta Bio) - Bozor kapitallashuvi|Ventyx Biosciences Inc. (VTYX) - Bozor kapitallashuvi|Bozor kapitallashuvi THTX|AVTX: Bozor bahosi|Bozor qiymati Eledon Pharmaceuticals ELDN|agenusbio.com (AGEN) - Bozor qiymati|CLYM - Bozor qiymati|ZURA: Bozor qiymati|aTyr (ATYR) - Bozor qiymati|ADAG - Bozor kapitallashuvi|Bozor bahosi IMA|STTK: Bozor qiymati|Bozor qiymati Equillium, Inc. (EQ)|Bozor kapitallashuvi connectbiopharm.com|Immunic - Bozor bahosi|Bozor kapitallashuvi Atara Biotherapeutics, Inc. (ATRA)|InflaRx GmbH - Bozor kapitallashuvi|XFOR - Bozor kapitallashuvi|ACET (adicetbio.com) - Bozor bahosi|CELU - Bozor kapitallashuvi|INMB (INmune Bio Corp) - Bozor kapitallashuvi|BRNS - Bozor kapitallashuvi|Bozor qiymati Kezar Life Sciences (KZR)|SABS (sabbiotherapeutics.com) - Bozor qiymati|Bozor kapitallashuvi AKTX (Akari Therapeutics Plc)|ENLV (Enlivex Therapeutics Ltd) - Bozor bahosi|QTTB - Bozor qiymati|Bozor kapitallashuvi GeoVax Corp GOVX|Edesa Biotech, Inc. (EDSA) - Bozor qiymati|Bozor bahosi IBIO (ibioinc.com)|CARM (Carisma Therapeutics Inc) - Bozor kapitallashuvi|XTLB: Bozor qiymati|Bozor kapitallashuvi BOLT|Bozor kapitallashuvi hcwbiologics.com (HCWB)|Bozor qiymati Aptevo Therapeutics Inc. APVO|Bozor qiymati AIM|ADTX - Bozor qiymati|GRI Bio Inc (GRI) - Bozor bahosi|XRTX: Bozor kapitallashuvi|Vyome Therapeutics (HIND) - Bozor kapitallashuvi|Bozor bahosi REVB|INDP: Bozor qiymati|Bozor kapitallashuvi SCNI|Bozor kapitallashuvi calcimedica.com|Bozor qiymati Affimed N.V. AFMD|ALLK - Bozor bahosi|HOOK - Bozor qiymati|IGM Biosciences, Inc. (IGMS) - Bozor bahosi|ITOS (iTeos Therapeutics, Inc.) - Bozor bahosi|Ocean Biomedical Inc (OCEA) - Bozor kapitallashuvi|Bozor qiymati TC BioPharm (Holdings) PLC|Bozor kapitallashuvi THRD (Third Harmonic Bio Inc)
